(Q43442158)

23 November 2017

title

The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions (English)

1 reference

23 November 2017

0 references

3

P Lindgren

1 reference

23 November 2017

G Kobelt

1

1 reference

23 November 2017

B Texier-Richard

series ordinal

2

1 reference

23 November 2017

publication date

21 April 2009

1 reference

Multiple Sclerosis Journal

23 November 2017

published in

1 reference

23 November 2017

volume

15

1 reference

23 November 2017

issue

6

1 reference

23 November 2017

page(s)

741-751

1 reference

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102771

Cost-utility of interferon beta1b in the treatment of patients with active relapsing-remitting or secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102771

Costs and quality of life in multiple sclerosis: a cross-sectional study in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102771

Costs and quality of life of patients with multiple sclerosis in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102771

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102771

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102771

Economic evidence in multiple sclerosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102771

Estimation of the cost of MS in Europe: extrapolations from a multinational cost study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102771

The worldwide prevalence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102771

[The organisation of health care and epidemiology of multiple sclerosis in France]

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102771

The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102771

Sex ratio of multiple sclerosis in Canada: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102771

21 January 2018

Identifiers

DOI

10.1177/1352458509102771

1 reference

23 November 2017

1 reference